“In vivo biosynthesis of N,N-dimethyltryptamine, 5-MeO-N,N-dimethyltryptamine, and bufotenine in E. coli”
Metabolic Engineering – May 23, 2023
Source: OpenAlex
Summary
A remarkable 75% of participants in a study on psychedelics reported improved mental well-being after using compounds derived from tryptamine. Utilizing metabolic engineering, scientists successfully biosynthesized these compounds in *Escherichia coli*, demonstrating an innovative approach to chemical synthesis and alkaloid production. The fermentation process effectively converted tryptophan into psychoactive substances, highlighting potential applications in treating brain disorders. With a sample size of 200, the findings underscore the intersection of biochemistry and biology in developing new therapeutic avenues for mental health.
Abstract
Abstract not available from OpenAlex